Registration Strip Icon for discussion Regístrate para interactuar en nuestros foros activos para discutir con inversores de ideas afines.

IMV

IMV (IMV)

IMV Inc
Fecha:
Ordernar por:
 Showing the most relevant articles for your search:NASDAQ:IMV
FechaHoraFuenteTítuloSímboloCompañía
01/09/202315:00Business WireIMV Accepts an Offer from its Secured Lenders for the Sale of its Intellectual Property AssetsNASDAQ:IMVIMV Inc
26/07/202306:05Business WireIMV Inc. Announces Update on CCAA Proceedings and Sales and Investment Solicitation ProcessNASDAQ:IMVIMV Inc
08/05/202315:55Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:IMVIMV Inc
08/05/202315:30Business WireIMV Receives NASDAQ Delisting NoticeNASDAQ:IMVIMV Inc
02/05/202315:15PR Newswire (US)Horizon Technology Finance Announces First Quarter 2023 Financial ResultsNASDAQ:IMVIMV Inc
01/05/202311:30Business WireIMV Initiates Restructuring Proceedings Under the CCAA to Complete the Review of its Strategic AlternativesNASDAQ:IMVIMV Inc
31/03/202315:15Business WireIMV Receives Nasdaq Notification Regarding Minimum Bid Price DeficiencyNASDAQ:IMVIMV Inc
27/03/202315:15Business WireIMV Inc. Announces Changes to Its Board of DirectorsNASDAQ:IMVIMV Inc
16/03/202306:10Edgar (US Regulatory)Annual and Transition Report (foreign Private Issuer) (20-f)NASDAQ:IMVIMV Inc
16/03/202306:05Business WireIMV Inc. Announces Strategic Update as well as Fourth Quarter and Full Year 2022 Financial and Operational ResultsNASDAQ:IMVIMV Inc
09/03/202306:05Business WireIMV Inc. to Announce Fourth Quarter and Fiscal Year 2022 Results and Host a Conference Call and Webcast on March 16, 2023NASDAQ:IMVIMV Inc
14/02/202311:58Edgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:IMVIMV Inc
13/02/202306:05Business WireIMV Inc. Presents Positive Initial Results From The MVP-S Phase 2B VITALIZE TrialNASDAQ:IMVIMV Inc
03/02/202311:07Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:IMVIMV Inc
08/01/202316:00Business WireIMV Inc. Announces Update and Planned 2023 Milestones to Advance Clinical Development of its Lead Therapeutic, MVP-SNASDAQ:IMVIMV Inc
21/12/202216:27Edgar (US Regulatory)Securities Registration: Employee Benefit Plan (s-8)NASDAQ:IMVIMV Inc
20/12/202211:37Business WireIMV Announces Closing of US$9 Million Registered Direct Offering Priced At-The-Market Under Nasdaq RulesNASDAQ:IMVIMV Inc
19/12/202216:26Edgar (US Regulatory)Voluntary Supplemental Material Filed Pursuant to Section 11(a) of the Securities Act of 1933 by Foreign Issuers (suppl)NASDAQ:IMVIMV Inc
16/12/202207:00Business WireIMV Announces US$9 Million Registered Direct Offering Priced At-The-Market Under Nasdaq RulesNASDAQ:IMVIMV Inc
15/12/202206:05Business WireIMV Inc. Announces Initial Data from the Ongoing Phase 2B VITALIZE Trial in Patients with r/r DLBCLNASDAQ:IMVIMV Inc
13/12/202206:05Business WireIMV Commences Trading on the TSX and Nasdaq Post-Reverse Stock SplitNASDAQ:IMVIMV Inc
25/07/202211:20Edgar (US Regulatory)Amended Registration Statement for Securities of Certain Canadian Issuers Under the Securities Act of 1933 (f-10/a)NASDAQ:IMVIMV Inc
11/07/202214:31Edgar (US Regulatory)Appointment of Agent for Service of Process and Undertaking (f-x)NASDAQ:IMVIMV Inc
11/07/202214:06Edgar (US Regulatory)Registration Statement for Securities of Certain Canadian Issuers Under the Securities Act of 1933 (f-10)NASDAQ:IMVIMV Inc
23/06/202204:40TipRanksH.C. Wainwright Thinks IMV’s Stock is Going to RecoverNASDAQ:IMVIMV Inc
18/04/202204:04TipRanksAnalysts Offer Insights on Healthcare Companies: and IMV (IMV)NASDAQ:IMVIMV Inc
14/04/202222:27TipRanksIMV (IMV) Receives a Buy from Wells FargoNASDAQ:IMVIMV Inc
13/04/202205:16TipRanksIMV (IMV) Gets a Buy Rating from H.C. WainwrightNASDAQ:IMVIMV Inc
17/03/202206:08Edgar (US Regulatory)Annual Report (foreign Private Issuer) (40-f)NASDAQ:IMVIMV Inc
22/12/202118:06TipRanksIMV (IMV) Gets a Hold Rating from Raymond JamesNASDAQ:IMVIMV Inc
 Showing the most relevant articles for your search:NASDAQ:IMV